Atlas Trials

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Clinical trial NCT03199274 · COMPLETED

Trial details

NCT number
NCT03199274
Sponsor
Thomas Jefferson University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2017-07-01
Primary completion
2024-02-27
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.